These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31532934)

  • 21. Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade.
    Tobin K; Clyde C; Davey-Rothwell M; Latkin C
    Int J Drug Policy; 2018 Sep; 59():94-97. PubMed ID: 30075401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center.
    Zschoche JH; Nesbit S; Murtaza U; Sowell A; Waldfogel JM; Arwood N; Rush J; McNamara L; Swarthout M; Nesbit T; Ortmann M
    Am J Health Syst Pharm; 2018 Nov; 75(22):1812-1820. PubMed ID: 30076167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergency Nurse Perceptions of Naloxone Distribution in the Emergency Department.
    Punches BE; Soliman S; Freiermuth CE; Lane BH; Lyons MS
    J Emerg Nurs; 2020 Sep; 46(5):675-681.e1. PubMed ID: 32828483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-Based Guidelines for EMS Administration of Naloxone.
    Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
    Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
    Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
    JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective Use of Naloxone by Law Enforcement in Response to Multiple Opioid Overdoses.
    Kitch BB; Portela RC
    Prehosp Emerg Care; 2016; 20(2):226-9. PubMed ID: 27002349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts.
    Lim JK; Forman LS; Ruiz S; Xuan Z; Callis BP; Cranston K; Walley AY
    Drug Alcohol Depend; 2019 Nov; 204():107531. PubMed ID: 31526959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public attitudes and beliefs about Virginia community pharmacists dispensing and administering naloxone.
    Haggerty LC; Gatewood SS; Goode JKR
    J Am Pharm Assoc (2003); 2018; 58(4S):S73-S77.e1. PubMed ID: 30006189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
    Winston I; McDonald R; Tas B; Strang J
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
    Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
    Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey.
    Cone DC; Bogucki S; Burns K; D'Onofrio G; Hawk K; Joseph D; Fiellin DA
    J Addict Med; 2020 Dec; 14(6):e369-e371. PubMed ID: 33031212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA.
    Bessen S; Metcalf SA; Saunders EC; Moore SK; Meier A; McLeman B; Walsh O; Marsch LA
    Int J Drug Policy; 2019 Dec; 74():144-151. PubMed ID: 31590090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.